Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Zhang B"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-9 z 9
    Tytuł:
    Correlation of MRI quantitative perfusion parameters with EGFR, VEGF and EGFR gene mutations in non-small cell cancer.
    Autorzy:
    Zou M; Department of Radiology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
    Zhang B; Department of Radiology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
    Shi L; Department of Radiology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
    Mao H; Department of Radiology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
    Huang Y; Department of Radiology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
    Zhao Z; Department of Radiology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2024 Feb 23; Vol. 14 (1), pp. 4447. Date of Electronic Publication: 2024 Feb 23.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
    Carcinoma, Non-Small-Cell Lung*/genetics
    Lung Neoplasms*/diagnostic imaging
    Lung Neoplasms*/genetics
    Carcinoma, Squamous Cell*/diagnostic imaging
    Carcinoma, Squamous Cell*/genetics
    Humans ; Vascular Endothelial Growth Factor A/genetics ; Genes, erbB-1 ; Contrast Media ; Magnetic Resonance Imaging/methods ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Perfusion ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    SP70-Targeted Imaging for the Early Detection of Lung Adenocarcinoma.
    Autorzy:
    Xu J; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Zhang S; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Zhang W; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Xie E; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Gu M; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Wang Y; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Yang L; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Zhang B; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Zhang J; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Gu C; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Xu T; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Li D; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Wang F; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Huang P; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
    Pan S; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Feb 13; Vol. 10 (1), pp. 2509. Date of Electronic Publication: 2020 Feb 13.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Adenocarcinoma of Lung/*diagnostic imaging
    Antibodies, Monoclonal/*analysis
    Lung Neoplasms/*diagnostic imaging
    Animals ; Biomarkers, Tumor/analysis ; Cell Line, Tumor ; Early Detection of Cancer ; Fluorescent Dyes/analysis ; Humans ; Immunoconjugates/analysis ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Molecular Imaging ; Optical Imaging
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients.
    Autorzy:
    Jiang R; Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.; Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.; Department of Pathology, The First Hospital of Lanzhou University, Lanzhou, 730000, China.
    Zhang B; Department of Pathology, Peking University Third Hospital, Beijing, 100191, China.
    Teng X; Department of Pathology, The First Affiliated Hospital, Zhejiang University, Hangzhou, 310003, China.
    Hu P; Department of Pathology, Xijing Hospital, Air Force Medical University, Xian, 710032, China.
    Xu S; Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, 430030, China.
    Zheng Z; Singlera Genomics Inc., Shanghai, 201318, China.
    Liu R; Singlera Genomics Inc., Shanghai, 201318, China.
    Tang T; Singlera Genomics Inc., Shanghai, 201318, China.
    Ye F; Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China. .; Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Feb 07; Vol. 10 (1), pp. 2070. Date of Electronic Publication: 2020 Feb 07.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Carcinoma, Non-Small-Cell Lung/*genetics
    High-Throughput Nucleotide Sequencing/*methods
    Lung Neoplasms/*genetics
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; China ; Female ; Gene Frequency/genetics ; Genes, Neoplasm/genetics ; Humans ; Male ; Middle Aged ; Mutation/genetics ; Mutation, Missense/genetics ; Reproducibility of Results ; Sensitivity and Specificity ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4.
    Autorzy:
    Li H; The State Key Laboratory of Medical Genetics &School of Life Sciences, Central South University, Changsha, 410078, China.
    Ouyang R; Department of Respiratory Medicine, Respiratory Disease Research Institute, Second XiangYa Hospital of Central South University, Changsha, 410011, China.
    Wang Z; The State Key Laboratory of Medical Genetics &School of Life Sciences, Central South University, Changsha, 410078, China.
    Zhou W; The State Key Laboratory of Medical Genetics &School of Life Sciences, Central South University, Changsha, 410078, China.
    Chen H; The State Key Laboratory of Medical Genetics &School of Life Sciences, Central South University, Changsha, 410078, China.
    Jiang Y; The State Key Laboratory of Medical Genetics &School of Life Sciences, Central South University, Changsha, 410078, China.
    Zhang Y; The State Key Laboratory of Medical Genetics &School of Life Sciences, Central South University, Changsha, 410078, China.
    Li H; The State Key Laboratory of Medical Genetics &School of Life Sciences, Central South University, Changsha, 410078, China.
    Liao M; The State Key Laboratory of Medical Genetics &School of Life Sciences, Central South University, Changsha, 410078, China.
    Wang W; Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, 410013, China.
    Ye M; Molecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Collaborative Innovation Center for Chemistry and Molecular Medicine, Hunan University, Changsha, 410082, China.
    Ding Z; Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, 400083, China.
    Feng X; Institute of Medical Sciences, Xiangya Hospital, Central South University, Changsha, 410078, China.
    Liu J; The State Key Laboratory of Medical Genetics &School of Life Sciences, Central South University, Changsha, 410078, China.
    Zhang B; Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, 410013, China.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2016 Dec 15; Vol. 6, pp. 39001. Date of Electronic Publication: 2016 Dec 15.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Carcinoma, Non-Small-Cell Lung/*metabolism
    Lung Neoplasms/*metabolism
    MicroRNAs/*metabolism
    Neoplasm Proteins/*metabolism
    RNA, Neoplasm/*metabolism
    Transcription Factors/*metabolism
    A549 Cells ; Animals ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Cycle Proteins ; Female ; Forkhead Transcription Factors ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Male ; Mice, Nude ; MicroRNAs/genetics ; Neoplasm Metastasis ; Neoplasm Proteins/genetics ; RNA, Neoplasm/genetics ; Transcription Factors/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis.
    Autorzy:
    Zhang H; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Lung Cancer Center.
    Gao L; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Lung Cancer Center.
    Zhang B; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Lung Cancer Center.
    Zhang L; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Lung Cancer Center.
    Wang C; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Lung Cancer Center.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2016 Mar 04; Vol. 6, pp. 22618. Date of Electronic Publication: 2016 Mar 04.
    Typ publikacji:
    Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
    MeSH Terms:
    Blood Platelets/*pathology
    Carcinoma, Non-Small-Cell Lung/*diagnosis
    Lung Neoplasms/*diagnosis
    Lymphocytes/*pathology
    Carcinoma, Non-Small-Cell Lung/pathology ; Cell Count ; Humans ; Lung Neoplasms/pathology ; Predictive Value of Tests ; Prognosis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation.
    Autorzy:
    Yin M; 1] The State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China [2] School of Life Science, University of Science and Technology of China, Hefei, China.
    Ren X; 1] The State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China [2] School of Life Science, University of Science and Technology of China, Hefei, China.
    Zhang X; Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, China.
    Luo Y; Guangzhou RiboBio Co., Ltd, Guangzhou, China.
    Wang G; The State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
    Huang K; Guangzhou RiboBio Co., Ltd, Guangzhou, China.
    Feng S; Guangzhou RiboBio Co., Ltd, Guangzhou, China.
    Bao X; The State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
    Huang K; University of Chinese Academy of Sciences, Beijing, China.
    He X; School of Life Science, University of Science and Technology of China, Hefei, China.
    Liang P; 1] The State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China [2] University of Chinese Academy of Sciences, Beijing, China.
    Wang Z; The State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
    Tang H; Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, China.
    He J; Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, China.
    Zhang B; 1] The State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China [2] School of Life Science, University of Science and Technology of China, Hefei, China.
    Pokaż więcej
    Źródło:
    Oncogene [Oncogene] 2015 Feb 05; Vol. 34 (6), pp. 691-703. Date of Electronic Publication: 2014 Jan 27.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Lung Neoplasms/*genetics
    MicroRNAs/*genetics
    NF-kappa B/*genetics
    Transcription Factor RelA/*biosynthesis
    Tumor Suppressor Protein p53/*biosynthesis
    Animals ; Apoptosis ; Carcinogenesis/genetics ; Cell Line, Tumor ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Lung Neoplasms/pathology ; Mice ; MicroRNAs/metabolism ; NF-kappa B/metabolism ; Reactive Oxygen Species/metabolism ; Signal Transduction ; Transcription Factor RelA/genetics ; Tumor Suppressor Protein p53/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer.
    Autorzy:
    Liu L; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Xu HX; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Wang WQ; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Wu CT; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Chen T; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Qin Y; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Liu C; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Xu J; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Long J; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Zhang B; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Xu YF; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Ni QX; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Li M; 1] Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China [2] The Vivian L. Smith Department of Neurosurgery, University of Texas Medical School at Houston, Houston, TX, USA.
    Yu XJ; Pancreatic Cancer Institute, Fudan University; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
    Pokaż więcej
    Źródło:
    Oncogene [Oncogene] 2014 May 22; Vol. 33 (21), pp. 2728-36. Date of Electronic Publication: 2013 Jun 17.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Caveolin 1/*metabolism
    Lung Neoplasms/*metabolism
    Pancreatic Neoplasms/*metabolism
    RNA-Binding Proteins/*metabolism
    Animals ; Cell Line, Tumor ; Cell Membrane/metabolism ; Epithelial-Mesenchymal Transition ; Female ; Humans ; Kaplan-Meier Estimate ; Lung Neoplasms/mortality ; Lung Neoplasms/secondary ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Middle Aged ; Neoplasm Transplantation ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; Phosphatidylinositol 3-Kinases/metabolism ; Prognosis ; Protein Transport
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    37-kDa laminin receptor precursor promotes lung adenocarcinoma cell invasion and metastasis by epithelial-to-mesenchymal transition.
    Autorzy:
    Wang Y; Department of Pathology and Pathophysiology, Fourth Military Medical University, Xi'an, China.
    Dong H; Department of Pathology and Pathophysiology, Fourth Military Medical University, Xi'an, China.
    Xu M; People's Liberation Army 88 Hospital, Tai'an, China.
    Xin B; People's Liberation Army 88 Hospital, Tai'an, China.
    Niu W; Department of Pathology and Pathophysiology, Fourth Military Medical University, Xi'an, China.
    Xu D; Department of Pathology and Pathophysiology, Fourth Military Medical University, Xi'an, China.
    Zhao P; Department of Pathology and Pathophysiology, Fourth Military Medical University, Xi'an, China.
    Zhang B; Department of Pathology and Pathophysiology, Fourth Military Medical University, Xi'an, China.
    Li Z; Department of Pathology and Pathophysiology, Fourth Military Medical University, Xi'an, China.
    Liu L; Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
    Pokaż więcej
    Źródło:
    Cancer gene therapy [Cancer Gene Ther] 2014 Apr; Vol. 21 (4), pp. 150-7. Date of Electronic Publication: 2014 Apr 11.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Adenocarcinoma/*metabolism
    Adenocarcinoma/*pathology
    Cell Movement/*physiology
    Lung Neoplasms/*metabolism
    Lung Neoplasms/*pathology
    Receptors, Laminin/*biosynthesis
    Adenocarcinoma/genetics ; Adenocarcinoma of Lung ; Animals ; Cell Growth Processes/physiology ; Cell Line, Tumor ; Epithelial-Mesenchymal Transition/physiology ; Female ; Humans ; Lentivirus/genetics ; Lung Neoplasms/genetics ; Mice ; Mice, Nude ; Neoplasm Metastasis ; RNA, Messenger/biosynthesis ; RNA, Messenger/genetics ; Receptors, Laminin/genetics ; Transfection
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
    Autorzy:
    Su Y; Stem Cell Biology and Therapy Laboratory, The Children's Hospital of Chongqing Medical University, Chongqing, China.
    Wagner ER
    Luo Q
    Huang J
    Chen L
    He BC
    Zuo GW
    Shi Q
    Zhang BQ
    Zhu G
    Bi Y
    Luo J
    Luo X
    Kim SH
    Shen J
    Rastegar F
    Huang E
    Gao Y
    Gao JL
    Yang K
    Wietholt C
    Li M
    Qin J
    Haydon RC
    He TC
    Luu HH
    Pokaż więcej
    Źródło:
    Oncogene [Oncogene] 2011 Sep 15; Vol. 30 (37), pp. 3907-17. Date of Electronic Publication: 2011 Apr 04.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Bone Neoplasms/*metabolism
    Insulin-Like Growth Factor Binding Protein 5/*metabolism
    Lung Neoplasms/*metabolism
    Osteosarcoma/*metabolism
    Adolescent ; Adult ; Animals ; Apoptosis ; Bone Neoplasms/genetics ; Bone Neoplasms/pathology ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Child ; Down-Regulation ; Female ; Gene Expression Profiling ; Gene Knockdown Techniques ; Humans ; Insulin-Like Growth Factor Binding Protein 5/genetics ; Lung Neoplasms/genetics ; Lung Neoplasms/secondary ; Male ; Mice ; Mice, Nude ; Osteosarcoma/genetics ; Osteosarcoma/secondary ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-9 z 9

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies